Ono Pharmaceutical Co., Ltd.
4528.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥754 | ¥1,185 | ¥4,049 | ¥4,567 |
| - Cash | ¥205 | ¥166 | ¥96 | ¥69 |
| + Debt | ¥147 | ¥9 | ¥9 | ¥9 |
| Enterprise Value | ¥696 | ¥1,028 | ¥3,962 | ¥4,507 |
| Revenue | ¥487 | ¥503 | ¥447 | ¥361 |
| % Growth | -3.1% | 12.4% | 23.8% | – |
| Gross Profit | ¥339 | ¥376 | ¥337 | ¥268 |
| % Margin | 69.6% | 74.7% | 75.4% | 74.1% |
| EBITDA | ¥92 | ¥182 | ¥162 | ¥123 |
| % Margin | 18.8% | 36.2% | 36.2% | 34% |
| Net Income | ¥50 | ¥128 | ¥113 | ¥81 |
| % Margin | 10.3% | 25.5% | 25.2% | 22.3% |
| EPS Diluted | 106.41 | 266.6 | 230.79 | 162.16 |
| % Growth | -60.1% | 15.5% | 42.3% | – |
| Operating Cash Flow | ¥82 | ¥111 | ¥160 | ¥62 |
| Capital Expenditures | -¥8 | -¥21 | -¥14 | -¥12 |
| Free Cash Flow | ¥74 | ¥90 | ¥145 | ¥50 |